Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation
NCT00779792 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2008-10-24
Summary
The purpose of this study is to compare the efficacy of glycerol ointment, triamcinolone acetonide ointment, clobetasol ointment and tacrolimus ointment on irritated skin in a cumulative skin irritation test model using healthy volunteers.
Conditions
- Dermatitis, Contact
- Dermatitis, Occupational
Interventions
- DRUG
-
clobetasol
0.5 mg Clobetasol propionate (0.5 mg/g) ointment applied twice daily for 10 consecutive days
- DRUG
-
triamcinolone acetonide
0.5 mg ointment twice daily for 10 consecutive days
- DRUG
-
0.5 mg tacrolimus ointment(0.1%) twice daily for 10 consecutive days
- DRUG
-
glycerol
0.5 mg glycerol ointment (20%) twice daily for 10 consecutive days
- DRUG
-
vehicle ointment (paraffin oil/soft white paraffin)
0.5 mg vehicle ointment twice daily for 10 consecutive days
Sponsors & Collaborators
-
LEO Pharma
collaborator INDUSTRY -
University of Southern Denmark
collaborator OTHER -
Odense University Hospital
lead OTHER
Principal Investigators
-
Anders Clemmensen, MD · Department of Dermatology, Odense University Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2008-11-30
- Completion
- 2008-11-30
Countries
- Denmark
Study Locations
More Related Trials
-
Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis
NCT00667056 ·Status: COMPLETED ·Phase: PHASE4
-
Distribution of Tacrolimus in Skin, Atopic Dermatitis
NCT00534508 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients
NCT00523952 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone
NCT05607901 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment
NCT00480610 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis
NCT00610142 ·Status: COMPLETED ·Phase: PHASE2
-
Study of 0417 Ointment in the Treatment of Atopic Dermatitis
NCT01139450 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis
NCT00833079 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
NCT00691262 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)
NCT02376049 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis
NCT01005823 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis
NCT02118792 ·Status: COMPLETED ·Phase: PHASE3
-
Infant Fecal Insult Study
NCT02979210 ·Status: COMPLETED ·Phase: NA
-
Clinical Observation of Topical Lidocaine Cream Combined With Moisturizing Cream in the Treatment of Atopic Dermatitis
NCT07067541 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis
NCT02732314 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Study of Topical GSK2894512 Cream
NCT02466152 ·Status: COMPLETED ·Phase: PHASE1
-
Pimecrolimus and Epidermal Barrier Function
NCT01132079 ·Status: COMPLETED ·Phase: NA
-
LEO19123 Cream in the Treatment of Atopic Dermatitis
NCT00392067 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of an Anti-TRPM8 in the Atopic Dermatitis Pruritus
NCT03610386 ·Status: COMPLETED ·Phase: NA
-
The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover
NCT04114097 ·Status: COMPLETED ·Phase: PHASE4
-
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
NCT02601703 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis
NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis
NCT00690833 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch
NCT03943407 ·Status: WITHDRAWN ·Phase: NA
-
KM110329 in Adult Patients With Atopic Dermatitis
NCT01692093 ·Status: UNKNOWN ·Phase: PHASE2